National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting, 43993 [2010-18385]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 143 / Tuesday, July 27, 2010 / Notices
Development Status: In clinical trials.
Market: An estimated three million
individuals in the United States will
have an advanced form of AMD by 2020
(Klein R et al. The epidemiology of agerelated macular degeneration. Am J
Ophthalmol. 2004;137(3):486–95).
Inventors: Robert B. Nussenblatt and
Frederick L. Ferris (NEI).
Publication: In preparation.
Patent Status: U.S. Provisional
Application No. 61/254,439 filed 23 Oct
2009 (HHS Reference No. E–198–2008/
0–US–01).
Licensing Status: Available for
licensing.
Licensing Contact: Norbert Pontzer,
J.D., PhD; 301–435–5502;
pontzern@mail.nih.gov.
Collaborative Research Opportunity:
The National Eye Institute, Laboratory
of Immunology, is seeking statements of
capability or interest from parties
interested in collaborative research to
further develop, evaluate, or
commercialize the use of
immunosuppressive agents in the
treatment of age related macular
degeneration. This is in light of new
findings that immune mechanisms
appear to be central to the expression of
the clinical disease we know as AMD.
Please contact Alan Hubbs, PhD at 301–
594–4263 or hubbsa@mail.nih.gov for
more information.
Dated: July 12, 2010.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2010–17446 Filed 7–26–10; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
sroberts on DSKD5P82C1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Patient Protection
and Affordable Care Act (PPACA),
Emerging Infections Program (EIP),
Enhancing Epidemiology and
Laboratory Capacity, Funding
Opportunity Announcement CI10–003;
Initial Review; Correction
Correction: This notice was published
in the Federal Register on July 7, 2010,
Volume 75, Number 129, page 39033.
The time and date should read as
follows:
Time and Date: 8 a.m.–5 p.m.,
September 8, 2010 (Closed).
CONTACT PERSON FOR MORE INFORMATION:
Gregory Anderson, M.S., M.P.H.,
VerDate Mar<15>2010
16:30 Jul 26, 2010
Jkt 220001
Scientific Review Officer, CDC, 1600
Clifton Road, NE., Mailstop E60,
Atlanta, GA 30333, Telephone: (404)
498–2293.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: July 20, 2010.
Michael J. Lanzilotta,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2010–18401 Filed 7–26–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council for
Biomedical Imaging and Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering, NACBIB September 2010.
Date: September 13, 2010.
Open: 9 a.m. to 1 p.m.
Agenda: Report from the Institute Director,
other Institute Staff and presentations of
working group reports.
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
43993
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Independence Room
(2nd Level), Bethesda, MD 20817.
Closed: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Independence Room
(2nd Level), Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD,
Director, National Institute of Biomedical
Imaging and Bioengineering, 6707
Democracy Boulevard, Room 241, Bethesda,
MD 20892.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib1.nih.gov/about/NACBIB/
NACBIB.htm, where an agenda and any
additional information for the meeting will
be posted when available.
Dated: July 21, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–18385 Filed 7–26–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Service
Administration
Advisory Committee on
Interdisciplinary, Community-Based
Linkages; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on
Interdisciplinary, Community-Based
Linkages (ACICBL).
Dates and Times:
August 19, 2010, 8:30 a.m. to 5 p.m., EST.
August 20, 2010, 8:30 a.m. to 3 p.m., EST.
Place: Hilton Washington DC/Rockville
Hotel & Executive Meeting Ctr, 1750
Rockville Pike, Rockville, Maryland 20852.
Status: The meeting will be open to the
public.
Purpose: The Committee members will
advance their efforts in the development of
the Tenth Annual Report to the Secretary of
the Department of Health and Human
Services (the Secretary) and the Congress,
focusing on the topic, Preparing the
Interprofessional Workforce to Manage
Health Behaviors. The Committee proposes
to review concepts behind the initiation of a
new degree program in Health Care Delivery
Science established at Dartmouth University
as it relates to managing health behaviors and
ensuring a workforce that is prepared to
address health behaviors in its education and
E:\FR\FM\27JYN1.SGM
27JYN1
]]>Agencies
[Federal Register Volume 75, Number 143 (Tuesday, July 27, 2010)]
[Notices]
[Page 43993]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18385]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council for Biomedical Imaging and Bioengineering.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Biomedical
Imaging and Bioengineering, NACBIB September 2010.
Date: September 13, 2010.
Open: 9 a.m. to 1 p.m.
Agenda: Report from the Institute Director, other Institute
Staff and presentations of working group reports.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Independence Room (2nd Level), Bethesda, MD 20817.
Closed: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Independence Room (2nd Level), Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD, Director, National
Institute of Biomedical Imaging and Bioengineering, 6707 Democracy
Boulevard, Room 241, Bethesda, MD 20892.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nibib1.nih.gov/about/NACBIB/NACBIB.htm, where an
agenda and any additional information for the meeting will be posted
when available.
Dated: July 21, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-18385 Filed 7-26-10; 8:45 am]
BILLING CODE 4140-01-P
